Apogee Therapeutics, Inc.
APGE
$38.76
$2.416.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 505.42M | 513.33M | 520.65M | 526.05M | 676.23M |
| Total Receivables | 4.14M | 5.01M | 4.70M | 4.77M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.60M | 2.61M | 2.62M | 3.27M | 2.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 963.00K | 586.00K | 1.74M | 396.00K | 3.39M |
| Total Current Assets | 516.12M | 521.53M | 529.71M | 534.48M | 681.85M |
|
|
|||||
| Total Current Assets | 516.12M | 521.53M | 529.71M | 534.48M | 681.85M |
| Net Property, Plant & Equipment | 17.02M | 17.19M | 13.32M | 13.54M | 4.94M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.86M | 7.34M | 498.00K | 514.00K | 468.00K |
| Total Assets | 657.77M | 714.16M | 753.95M | 776.29M | 800.66M |
|
|
|||||
| Total Accounts Payable | 5.68M | 2.45M | 1.07M | 2.22M | 5.53M |
| Total Accrued Expenses | 21.85M | 26.54M | 24.26M | 27.53M | 17.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.03M | 3.98M | 3.23M | 2.87M | 1.68M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 31.55M | 32.96M | 28.56M | 32.61M | 24.62M |
|
|
|||||
| Total Current Liabilities | 31.55M | 32.96M | 28.56M | 32.61M | 24.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.82M | 7.84M | 8.60M | 9.27M | 2.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.37M | 40.80M | 37.16M | 41.88M | 27.02M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.03B | 1.02B | 969.83M | 963.61M |
| Retained Earnings | -427.35M | -361.26M | -305.92M | -238.70M | -189.68M |
| Treasury Stock & Other | 685.00K | 1.07M | 915.00K | 3.27M | -289.00K |
| Total Common Equity | 619.40M | 673.36M | 716.79M | 734.40M | 773.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 619.40M | 673.36M | 716.79M | 734.40M | 773.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 619.40M | 673.36M | 716.79M | 734.40M | 773.64M |
|
|
|||||